Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Routy B, et al. Among authors: zitvogel l. Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2. Science. 2018. PMID: 29097494
Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12).
Merad M, Angevin E, Wolfers J, Flament C, Lorenzi I, Triebel F, Escudier B, Zitvogel L. Merad M, et al. Among authors: zitvogel l. J Immunother. 2000 May-Jun;23(3):369-78. doi: 10.1097/00002371-200005000-00010. J Immunother. 2000. PMID: 10838666 Clinical Trial.
Dendritic cell-based immunotherapy of cancer.
Zitvogel L, Angevin E, Tursz T. Zitvogel L, et al. Ann Oncol. 2000;11 Suppl 3:199-205. doi: 10.1093/annonc/11.suppl_3.199. Ann Oncol. 2000. PMID: 11079142 Free article. Review. No abstract available.
Exosomes in cancer immunotherapy: preclinical data.
Andre F, Andersen M, Wolfers J, Lozier A, Raposo G, Serra V, Ruegg C, Flament C, Angevin E, Amigorena S, Zitvogel L. Andre F, et al. Among authors: zitvogel l. Adv Exp Med Biol. 2001;495:349-54. doi: 10.1007/978-1-4615-0685-0_49. Adv Exp Med Biol. 2001. PMID: 11774591 Review. No abstract available.
Malignant effusions and immunogenic tumour-derived exosomes.
Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L. Andre F, et al. Among authors: zitvogel l. Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1. Lancet. 2002. PMID: 12147373
Tumor-derived exosomes: a new source of tumor rejection antigens.
André F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: zitvogel l. Vaccine. 2002 Dec 19;20 Suppl 4:A28-31. doi: 10.1016/s0264-410x(02)00384-5. Vaccine. 2002. PMID: 12477425 Review.
[Exosomes and anti-tumour immunotherapy].
Chaput N, Andre F, Schartz NE, Flament C, Angevin E, Escudier B, Zitvogel L. Chaput N, et al. Among authors: zitvogel l. Bull Cancer. 2003 Aug-Sep;90(8-9):695-8. Bull Cancer. 2003. PMID: 14609758 Free article. Clinical Trial. French.
593 results